» Download Public Reports
17 reports
- Country report
- October 2010
- 22 pages
... For every stages pharmaceutical development development clinical trial supplies supplies regulatory affairs affairs production & packaging aging distribution api sourcing formulation and/or process ...
January 2011
... Regarding nutraceutical and investigational product cands and clinical trials and the status and related results thereto, as well those regarding continuing and further development efforts ...
December 2009
... Equivalents, compared with cash and cash equivalents of eur 11.49 Million as of december 31, 2008. Absent the need to fund any additional clinical trials, management believes that the company S cash and cash ...
March 2011
... In a non-interest bearing loan from an insider of the company. Announced signing of $8,000,000 investment financing arrangement to support the company S clinical trial programs, with $500,000 of funding ...
March 2011
... Better gastrointestinal tolerability and pharmacokinetic profile than tramiprosate company seeking a potential partnership to pursue development process phase i clinical trial pharmascience leading ...
December 2011
... And complete a new clinical trial of defibrotide, to start over in the enrollment of the historical control arm, or to enroll additional patients in the historical control arm. To the extent that we ...
December 2011
... And manageable toxicities when administered at the proposed dose and schedule in the extend clinical trial in heavily pre-treated patients. The most common (incidence greater than or equal to 10%) grade 3 ...
March 2011
... trial costs (plus eur 1.8 Million) and higher personnel expenses (plus 0.7 Million) mainly due to an increase of total personnel by 14 persons to 161 persons. Cost of goods sold increased by 9 ...
September 2010
... Of research in drug discovery, the journal of industrial economics 46(2), 157{182. Das, s., Roberts, m.J. And tybout, j.R.: 2007, Market entry costs, producer heterogeneity, and export dynamics, econometrica 75 ...
March 2012
... Biotech holding ag ( Mondobiotech ) A swiss - based unconventional drug discovery company focused on rare and neglected diseases listed and traded on the six swiss exchange (six: rare) announce today ...